EW vs XBPEW · P/E 47, rev $3.39B vs rev $191.3M
Edwards Lifesciences Corp (EW) versus XBP Europe Holdings Inc (XBPEW) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
XBP Europe Holdings Inc (XBPEW) is a software - infrastructure company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported XBPEW revenue for 2026-06-30 was $191.3M. Net income was -$16.7M. Revenue was down 3.0% from 2026-03-31 to 2026-06-30. XBPEW currently screens at market cap $0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. XBPEW currently screens at market cap $0.
Not investment advice. Open the EW and XBPEW stock pages for the full models.
Not investment advice.